{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:22:05Z","timestamp":1781101325006,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yingsong Wu"},{"name":"Shouchun Cao","award":["2023SKLDRS0111"],"award-info":[{"award-number":["2023SKLDRS0111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-025-01036-7","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:59:32Z","timestamp":1758880772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel single-vector featuring bidirectional promoters for production of bispecific antibody against rabies virus"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhigao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1036_CR1","unstructured":"Swinkels HM, Koury R, Warrington SJ. Rabies. In: StatPearls. Treasure Island (FL). 2025."},{"issue":"1","key":"1036_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/01652176.2017.1343516","volume":"37","author":"R Singh","year":"2017","unstructured":"Singh R, Singh KP, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy GB, Panda S, Dhama K. Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q. 2017;37(1):212\u201351.","journal-title":"Vet Q"},{"key":"1036_CR3","doi-asserted-by":"publisher","first-page":"786953","DOI":"10.3389\/fimmu.2021.786953","volume":"12","author":"TP Scott","year":"2021","unstructured":"Scott TP, Nel LH. Lyssaviruses and the fatal encephalitic disease rabies. Front Immunol. 2021;12:786953.","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"1036_CR4","doi-asserted-by":"publisher","first-page":"A140","DOI":"10.1016\/j.vaccine.2018.08.039","volume":"37","author":"AR Fooks","year":"2019","unstructured":"Fooks AR, Banyard AC, Ertl HCJ. New human rabies vaccines in the pipeline. Vaccine. 2019;37(Suppl 1):A140\u20135.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"1036_CR5","doi-asserted-by":"publisher","first-page":"A132","DOI":"10.1016\/j.vaccine.2018.11.004","volume":"37","author":"E Sparrow","year":"2019","unstructured":"Sparrow E, Torvaldsen S, Newall AT, Wood JG, Sheikh M, Kieny MP, Abela-Ridder B. Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline. Vaccine. 2019;37(Suppl 1):A132\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"1036_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","volume":"101","author":"K Suwansrinon","year":"2007","unstructured":"Suwansrinon K, Jaijareonsup W, Wilde H, Benjavongkulchai M, Sriaroon C, Sitprija V. Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans R Soc Trop Med Hyg. 2007;101(2):206\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"1036_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1086\/500470","volume":"193","author":"J Goudsmit","year":"2006","unstructured":"Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif J, Dietzschold B, Bakker AB, Rupprecht CE. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune Globulin. J Infect Dis. 2006;193(6):796\u2013801.","journal-title":"J Infect Dis"},{"key":"1036_CR8","doi-asserted-by":"crossref","unstructured":"de Melo GD, Hellert J, Gupta R, Corti D, Bourhy H. Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy. Curr Opin Virol. 2022;53.","DOI":"10.1016\/j.coviro.2022.101204"},{"issue":"2","key":"1036_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/ijp.ijp_18_23","volume":"55","author":"VK Kaza","year":"2023","unstructured":"Kaza VK, Nathan B. Inclusion of rabishield in the WHO guidelines for rabies postexposure prophylaxis. Indian J Pharmacol. 2023;55(2):141\u20132.","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"1036_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/14712598.2016.1150996","volume":"16","author":"A Thakur","year":"2016","unstructured":"Thakur A, Lum LG. \u201cNextGen\u201d biologics: bispecific antibodies and emerging clinical results. Expert Opin Biol Ther. 2016;16(5):675\u201388.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1036_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/21645515.2016.1251536","volume":"13","author":"EK Nyakatura","year":"2017","unstructured":"Nyakatura EK, Soare AY, Lai JR. Bispecific antibodies for viral immunotherapy. Hum Vaccin Immunother. 2017;13(4):836\u201342.","journal-title":"Hum Vaccin Immunother"},{"key":"1036_CR12","doi-asserted-by":"crossref","unstructured":"Wang Q, Chen Y, Park J, Liu X, Hu Y, Wang T, McFarland K, Betenbaugh MJ. Design and production of bispecific antibodies. Antibodies (Basel). 2019;8(3).","DOI":"10.3390\/antib8030043"},{"issue":"8","key":"1036_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14712598.2022.2095900","volume":"22","author":"DJ Underwood","year":"2022","unstructured":"Underwood DJ, Bettencourt J, Jawad Z. The manufacturing considerations of bispecific antibodies. Expert Opin Biol Ther. 2022;22(8):1043\u201365.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"1036_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nbt1252","volume":"24","author":"G Walsh","year":"2006","unstructured":"Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol. 2006;24(10):1241\u201352.","journal-title":"Nat Biotechnol"},{"key":"1036_CR15","doi-asserted-by":"publisher","first-page":"107552","DOI":"10.1016\/j.biotechadv.2020.107552","volume":"43","author":"R O\u2019Flaherty","year":"2020","unstructured":"O\u2019Flaherty R, Bergin A, Flampouri E, Mota LM, Obaidi I, Quigley A, Xie Y, Butler M. Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing. Biotechnol Adv. 2020;43:107552.","journal-title":"Biotechnol Adv"},{"issue":"1","key":"1036_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00253-024-13315-y","volume":"108","author":"Y Fu","year":"2024","unstructured":"Fu Y, Han Z, Cheng W, Niu S, Wang T, Wang X. Improvement strategies for transient gene expression in mammalian cells. Appl Microbiol Biotechnol. 2024;108(1):480.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1036_CR17","doi-asserted-by":"publisher","first-page":"856049","DOI":"10.3389\/fbioe.2022.856049","volume":"10","author":"JH Zhang","year":"2022","unstructured":"Zhang JH, Shan LL, Liang F, Du CY, Li JJ. Strategies and considerations for improving recombinant antibody production and quality in Chinese hamster ovary cells. Front Bioeng Biotechnol. 2022;10:856049.","journal-title":"Front Bioeng Biotechnol"},{"issue":"13\u201316","key":"1036_CR18","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1007\/s00253-022-12051-5","volume":"106","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li Z, Li Q, Ma K, Lin Y, Feng H, Wang T. Increase recombinant antibody yields through optimizing vector design and production process in CHO cells. Appl Microbiol Biotechnol. 2022;106(13\u201316):4963\u201375.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1036_CR19","first-page":"30","volume":"5","author":"ZS Heng","year":"2022","unstructured":"Heng ZS, Yeo JY, Koh DW, Gan SK, Ling WL. Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters. Antib Ther. 2022;5(1):30\u201341.","journal-title":"Antib Ther"},{"issue":"6","key":"1036_CR20","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s11033-018-4351-0","volume":"45","author":"YM Li","year":"2018","unstructured":"Li YM, Tian ZW, Xu DH, Wang XY, Wang TY. Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells. Mol Biol Rep. 2018;45(6):2907\u201312.","journal-title":"Mol Biol Rep"},{"key":"1036_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbt.2021.07.002","volume":"65","author":"A Napoleone","year":"2021","unstructured":"Napoleone A, Lauren I, Linkgreim T, Dahllund L, Persson H, Andersson O, Olsson A, Hultqvist G, Frank P, Hall M, et al. Fed-batch production assessment of a tetravalent bispecific antibody: a case study on piggybac stably transfected HEK293 cells. N Biotechnol. 2021;65:9\u201319.","journal-title":"N Biotechnol"},{"key":"1036_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-0716-1126-5_4","volume":"2247","author":"J Konig","year":"2021","unstructured":"Konig J, Hust M, van den Heuvel J. Validation of the production of antibodies in different formats in the HEK 293 transient gene expression system. Methods Mol Biol. 2021;2247:59\u201376.","journal-title":"Methods Mol Biol"},{"key":"1036_CR23","doi-asserted-by":"crossref","unstructured":"Carrara SC, Fiebig D, Bogen JP, Grzeschik J, Hock B, Kolmar H. Recombinant antibody production using a dual-promoter single plasmid system. Antibodies (Basel). 2021;10(2).","DOI":"10.3390\/antib10020018"},{"issue":"4","key":"1036_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2022.09.003","volume":"1","author":"C Shi","year":"2022","unstructured":"Shi C, Sun P, Yang P, Liu L, Tian L, Liu W, Wang M, Zheng X, Zheng W. Research progress on neutralizing epitopes and antibodies for the rabies virus. Infect Med. 2022;1(4):262\u201371.","journal-title":"Infect Med"},{"issue":"4","key":"1036_CR25","first-page":"288","volume":"5","author":"HK Ong","year":"2022","unstructured":"Ong HK, Nguyen NTB, Bi J, Yang Y. Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells. Antib Ther. 2022;5(4):288\u2013300.","journal-title":"Antib Ther"},{"issue":"2","key":"1036_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/10826068.2017.1421966","volume":"48","author":"H Bayat","year":"2018","unstructured":"Bayat H, Hossienzadeh S, Pourmaleki E, Ahani R, Rahimpour A. Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells. Prep Biochem Biotechnol. 2018;48(2):160\u20134.","journal-title":"Prep Biochem Biotechnol"},{"issue":"11","key":"1036_CR27","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/s41596-024-01016-9","volume":"19","author":"J Luan","year":"2024","unstructured":"Luan J, Song C, Liu Y, He R, Guo R, Cui Q, Jiang C, Li X, Hao K, Stewart AF, et al. Seamless site-directed mutagenesis in complex cloned DNA sequences using the RedEx method. Nat Protoc. 2024;19(11):3360\u201388.","journal-title":"Nat Protoc"},{"key":"1036_CR28","doi-asserted-by":"publisher","first-page":"140275","DOI":"10.1016\/j.ijbiomac.2025.140275","volume":"301","author":"H Mo","year":"2025","unstructured":"Mo H, Chen Q, Zhang Z, Lin G, Wang Y, Mo L, Liang W, He J, Su B, Li J, et al. Development of a blocking ELISA for evaluating neutralizing antibodies in human and canine serum based on rabies virus glycoprotein epitope I. Int J Biol Macromol. 2025;301:140275.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1036_CR29","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1038\/s41598-017-07687-7","volume":"7","author":"G Lin","year":"2017","unstructured":"Lin G, Chen S, Zhao H, Liang J, Deng Q, Liang R, Guo X, Chen Z, Chen B, Liu T, et al. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency. Sci Rep. 2017;7(1):7288.","journal-title":"Sci Rep"},{"issue":"1","key":"1036_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(92)90092-8","volume":"152","author":"MJ Coloma","year":"1992","unstructured":"Coloma MJ, Hastings A, Wims LA, Morrison SL. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods. 1992;152(1):89\u2013104.","journal-title":"J Immunol Methods"},{"issue":"1","key":"1036_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"1036_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12250-012-3247-8","volume":"27","author":"PC Yu","year":"2012","unstructured":"Yu PC, Noguchi A, Inoue S, Tang Q, Rayner S, Liang GD. Comparison of RFFIT tests with different standard sera and testing procedures. Virol Sin. 2012;27(3):187\u201393.","journal-title":"Virol Sin"},{"key":"1036_CR33","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1038\/srep42769","volume":"7","author":"J Nie","year":"2017","unstructured":"Nie J, Wu X, Ma J, Cao S, Huang W, Liu Q, Li X, Li Y, Wang Y. Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system. Sci Rep. 2017;7:42769.","journal-title":"Sci Rep"},{"key":"1036_CR34","unstructured":"Feinbaum R. Introduction to plasmid biology. Curr Protoc Mol Biol 2001, Chap. 1: Unit 1.5."},{"issue":"1","key":"1036_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0014-5793(99)01013-3","volume":"457","author":"K Tao","year":"1999","unstructured":"Tao K. In vivo oxidation-reduction kinetics of oxyr, the transcriptional activator for an oxidative stress-inducible Regulon in Escherichia coli. FEBS Lett. 1999;457(1):90\u20132.","journal-title":"FEBS Lett"},{"issue":"5","key":"1036_CR36","doi-asserted-by":"publisher","first-page":"a013201","DOI":"10.1101\/cshperspect.a013201","volume":"5","author":"I Braakman","year":"2013","unstructured":"Braakman I, Hebert DN. Protein folding in the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 2013;5(5):a013201.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1036_CR37","doi-asserted-by":"publisher","first-page":"1352014","DOI":"10.3389\/fbioe.2024.1352014","volume":"12","author":"AV Madsen","year":"2024","unstructured":"Madsen AV, Pedersen LE, Kristensen P, Goletz S. Design and engineering of bispecific antibodies: insights and practical considerations. Front Bioeng Biotechnol. 2024;12:1352014.","journal-title":"Front Bioeng Biotechnol"},{"key":"1036_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ddtec.2020.10.002","volume":"34","author":"F Dong","year":"2019","unstructured":"Dong F, Ghayur T. Recent advancements in DVD-Ig based therapeutic development. Drug Discov Today Technol. 2019;34:1\u20137.","journal-title":"Drug Discov Today Technol"},{"issue":"8","key":"1036_CR39","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1016\/S2214-109X(18)30302-4","volume":"6","author":"R Minghui","year":"2018","unstructured":"Minghui R, Stone M, Semedo MH, Nel L. New global strategic plan to eliminate dog-mediated rabies by 2030. Lancet Glob Health. 2018;6(8):e828\u20139.","journal-title":"Lancet Glob Health"},{"key":"1036_CR40","doi-asserted-by":"publisher","first-page":"102267","DOI":"10.1016\/j.tmaid.2022.102267","volume":"46","author":"LL Zhai","year":"2022","unstructured":"Zhai LL, Wang H, Zhao W, Zhang SF, Miao FM, Cao Y, Chen C, Li YF, Gao J, Lv RY, et al. Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models. Travel Med Infect Dis. 2022;46:102267.","journal-title":"Travel Med Infect Dis"},{"issue":"9","key":"1036_CR41","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/bit.28365","volume":"120","author":"B Bachhav","year":"2023","unstructured":"Bachhav B, de Rossi J, Llanos CD, Segatori L. Cell factory engineering: challenges and opportunities for synthetic biology applications. Biotechnol Bioeng. 2023;120(9):2441\u201359.","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"1036_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/biot.201500579","volume":"11","author":"JJ Priola","year":"2016","unstructured":"Priola JJ, Calzadilla N, Baumann M, Borth N, Tate CG, Betenbaugh MJ. High-throughput screening and selection of mammalian cells for enhanced protein production. Biotechnol J. 2016;11(7):853\u201365.","journal-title":"Biotechnol J"},{"issue":"4","key":"1036_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2022.09.003","volume":"1","author":"C Shi","year":"2022","unstructured":"Shi C, Sun P, Yang P, Liu L, Tian L, Liu W, Wang M, Zheng X, Zheng W. Research progress on neutralizing epitopes and antibodies for the rabies virus. Infect Med (Beijing). 2022;1(4):262\u201371.","journal-title":"Infect Med (Beijing)"},{"issue":"3","key":"1036_CR44","doi-asserted-by":"publisher","first-page":"e0195424","DOI":"10.1128\/jvi.01954-24","volume":"99","author":"C Chen","year":"2025","unstructured":"Chen C, Wang X, Su W, Tian Y, Gao Y, Liu D, Xiang H, Liu B, Jl S, Zhang Y, et al. Changes in the dynamic characteristics of G-protein can alter the immune-protection efficacy of rabies virus vaccine. J Virol. 2025;99(3):e0195424.","journal-title":"J Virol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-025-01036-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:59:34Z","timestamp":1758880774000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-025-01036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1186\/s12896-025-01036-7","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}